期刊文献+

康柏西普玻璃体内注射联合视网膜激光光凝术治疗糖尿病性黄斑水肿的疗效观察 被引量:10

Observation on Curative Effect of Intravitreal Injection of Conbercept combined with Retinal Laser Photocoagulation in the Treatment of Diabetic Macular Edema
下载PDF
导出
摘要 目的:探讨康柏西普玻璃体内注射联合视网膜激光光凝术治疗糖尿病性黄斑水肿(DME)的疗效。方法:选取2017年6月~2020年6月本院收治的500例DME患者作为研究对象,按照随机数字表法分为对照组和观察组,各250例。对照组采取视网膜激光光凝术治疗,观察组在对照组基础上联合康柏西普玻璃体内注射治疗。比较两组治疗前、治疗1个月、治疗3个月的最佳矫正视力(BCVA)、黄斑中心凹厚度(CMT),以及细胞因子[血管内皮生长因子(VEGF)、白细胞介素-6(IL-6)、可溶性细胞间黏附分子-1(sICAM-1)]水平;记录两组不良反应发生情况。结果:治疗1个月和3个月,观察组BCVA高于对照组(P<0.05),CMT及VEGF、IL-6、sICAM-1水平低于对照组(P<0.05)。治疗期间,两组不良反应总发生率比较无统计学差异(P>0.05)。结论:康柏西普玻璃体内注射联合视网膜激光光凝术能提高DME患者视力,降低视网膜厚度,疗效较好,且安全性较高。 Objective:To explore the curative effect of intravitreal injection of conbercept combined with retinal laser photocoagulation in the treatment of diabetic macular edema(DME).Methods:500 patients with DME treated in our hospital from June 2017 to June 2020 were selected as the research subjects.According to random number table method,they were divided into control group and observation group,with 250 cases in each group.The control group was treated with retinal laser photocoagulation,and the observation group was treated with conbercept intravitreal injection on the basis of the control group.Best corrected visual acuity(BCVA),central macular thickness(CMT),and levels of cytokines[vascular endothelial growth factor(VEGF),interleukin-6(IL-6)and soluble intercellular adhesion molecule-1(sICAM-1)]of the two groups were compared before treatment,1 month after treatment and 3 months after treatment.The adverse reactions of the two groups were recorded.Results:At 1 month after treatment and 3 months after treatment,BCVA of the observation group was higher than that of the control group(P<0.05),and CMT,VEGF,IL-6 and sICAM-1 were lower than those of the control group(P<0.05).During the treatment period,there was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion:Intravitreal injection of conbercept combined with retinal laser photocoagulation can improve visual acuity and reduce retinal thickness of patients with DME.It has good curative effect and high safety.
作者 李维欣 谢桂丽 孙晓敏 王宇鹰 LI Wei-xin;XIE Gui-li;SUN Xiao-min;WANG Yu-ying(Department of Ophthalmology II,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China;Department of Ophthalmology I,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China)
出处 《中国合理用药探索》 2022年第1期96-101,共6页 Chinese Journal of Rational Drug Use
基金 河南省高等学校重点科研项目计划(19B320031)。
关键词 康柏西普 视网膜激光光凝术 糖尿病性黄斑水肿 血管内皮生长因子 不良反应 conbercept retinal laser photocoagulation diabetic macular edema vascular endothelial growth factor adverse reaction
  • 相关文献

参考文献14

二级参考文献87

  • 1姚毅,王志军,姜荔,杨丙建,王玮,张卯年,林顺潮.玻璃体内注射曲安奈德治疗糖尿病性弥漫性黄斑水肿的初步观察[J].中华眼底病杂志,2005,21(4):217-219. 被引量:36
  • 2王海欣,张卯年.糖尿病黄斑水肿的早期诊断和治疗[J].国外医学(眼科学分册),2005,29(6):416-422. 被引量:15
  • 3International Diabetes Federation. IDF Diabetes Atlas: 7thEditon. 2015.
  • 4Center of Disease Control National Center of Chronic Disease Prevention & Health Promotion Division of Diabetes Translation, 2015.
  • 5International Diabetes Federation. IDF Diabetes Atlas: 6thEditon. 2013.
  • 6Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. ETDRS study report number 1 [J]. Arch Ophthalmol, 1985, 103 (12): 1796- 1806.
  • 7Massin P, Bandello F, Garweg JG, et al. Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESLOVE): a 12- month randomized, controlled, double-masked, multicenter phase II study [J]. Diabetes Care, 2010, 33(11) : 2399-2405.
  • 8Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edemaof the mAcula in diabetes (READ- 2) study[J]. Ophthalmology, 2010, 117(11):2146-2151.
  • 9Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: Ranibizumabmonotherapy or combined with laser versus monotherapy for diabetic macular edema [J]. Ophthalmology, 2011, 118 (4): 615-625.
  • 10Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic maeolar edema: Results from 2 phase HI randomized trials: RISE and RIDE [J]. Ophthalmology, 2012, 119 (4) : 789-801.

共引文献205

同被引文献97

引证文献10

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部